- My News
- All News
- Most Popular
Dublin, Ireland, 24th April 2018 …Today, on World Meningitis Day, HiberGene Diagnostics, a private Irish company, launched a new rapid, highly accurate combination test for meningococcal and pneumococcal meningitis.
The product, which covers up to 90% of cases of bacterial meningitis, is highly accurate, easy to use and gives results in less than 60 minutes. This is in comparison to traditional microbiological methods which can take up to 24 - 48 hours to deliver a result. As the diagnosis of bacterial meningitis is time-sensitive and requires targeted antibiotic therapy, the ability to provide a rapid and accurate result is a critical component in saving lives and preventing further transmission.
The test was developed by researchers in HiberGene’s Dublin-based facility and utilises a technology known as LAMP (loop-mediated isothermal amplification). Samples are incubated and read on HiberGene’s HG Swift instrument which provides and interprets results in real-time.
The HG Pneumo / Meningo Combo test expands HiberGene’s existing suite of meningitis tests which now comprises a total of five products. HiberGene also has products in the market in the areas of Group B Streptococcus, Clostridium difficile and Mycoplasma pneumoniae.
Commenting, Brendan Farrell, HiberGene CEO, said:
“HiberGene’s mission is to provide the world with a new generation of rapid diagnostic tests capable of saving time and thus saving lives. We believe our new combination test for meningococcal and pneumococcal meningitis is a breakthrough in the fight against bacterial meningitis. It is our fifth product in this area and we are delighted to be launching it on World Meningitis Day.”
The product will be marketed and sold through HiberGene’s global network of over 45 distributors, covering 60 countries, which includes Brennan & Co in Ireland.
HiberGene is currently raising approximately €5 million to expand its research and development and sales and marketing resources.
HiberGene Diagnostics is an innovator of rapid molecular tests for human infectious diseases. The company develops, manufactures and markets a portfolio of rapid diagnostic tests for life threatening diseases. The tests deliver results in under 60 minutes and have the potential to save lives and reduce healthcare costs. HiberGene is an Irish company based in Sandyford, Dublin, and employs 25 people. For further information, please see the company’s website at www.hibergene.com.
Did you like this article?